UK home care provider Cera has launched a flu-tracking and treatment app to support earlier diagnosis and faster treatment of flu in older population groups.
‘Flu-ID’ technology uses artificial intelligence and machine learning to detect deterioration in older people’s conditions as a result of flu. The app identifies flu up to thirty times faster than existing methods, prompting carers and...
London-based artificial intelligence (AI) provider, RwHealth, has announced a raise of €7.2 million ($8.4m) in Series A funding.
Maven VC and Guinness Asset Management led the round, along with ICON Corporate Finance.
WHAT IT DOES
Founded in 2017, RwHealth’s platform combines AI machine learning and data science to give healthcare providers access to data which can aid their decision-making....
Online searches for digital health products in the UK increased by 343% during the first lockdown, according to a new public health study.
Research scientists led by Simon Leigh, head of research at the Organisation for the Review of Health and Care Applications (ORCHA) examined web-based internet searches for digital health products before and during the COVID-19 pandemic.
The study, published...
Digital health firm Babylon has secured a sustainability-linked investment of up to $200 million (€173M) from the strategic capital investment firm, Albacore Capital Group.
Together with already committed PIPE capital of $230 million (€199M) from institutional and strategic investors, Babylon will now have access to around $775 million (€671M) of capital (before fees).
In June Babylon announced...
People across the South-West of England will be given access to digital health libraries, through a partnership between the Organisation for the Review of Care and Health Apps (ORCHA) and seven Integrated Care Systems (ICSs).
It follows the success of the Our Dorset programme, which allows health and care staff to recommend apps focused on mental health, dementia, diabetes and cancer support to...
The NHS today announced it is launching the world’s largest trial of a blood test which can detect more than 50 types of cancer before symptoms appear.
Research has shown the Galleri test is effective at finding cancers that are typically difficult to identify early, including head and neck, bowel, lung, pancreatic, and throat cancers.
It works by finding chemical changes in fragments of genetic...
UK GOVERNMENT ANNOUNCES £113M FUNDING TO BRING INNOVATION
Ninety-seven of the UK's future science leaders will benefit from a £113 million cash boost to help turn science into new products and services.
Announced by science minister Amanda Solloway this week, the boost will support projects such as robotics to help British farmers, new therapies to tackle chronic illnesses and unlocking the...
DigitalHealth.London has opened applications to their flagship Accelerator programme for the next generation of digital health companies to bolster health and care.
The NHS delivered programme has supported digital companies now being used by the NHS in London, including LIVI, Oxehealth, Patchwork Health, Echo, Sweatcoin, and Health Navigator.
Applications open today for six weeks. The deadline...
Medovate, a medical device development company in the United Kingdom, has announced its first partnership in the Middle East. The Cambridge-based specialist has teamed up with Kuwait’s Omneya Medical Co. to distribute its SAFIRA (SAFer Injection for Regional Anesthesia) device in the Gulf country.
Developed “in collaboration with clinicians from the National Health Service (NHS) in the UK,”...
gammaCore, a handheld device used to alleviate cluster headaches, is now availble through NHS England following successful trials.
The roll out of the medical device is supported by the Medtech Funding Mandate, which fast-tracks innovations in the NHS. This mandate is part of the NHS Long Term Plan and came into effect on 1 April 2021.
WHY IT MATTERS
gammaCore works to relieve pain by delivering...